Role of the interleukin 6 in hepatocellular carcinoma;ROLE DE L'INTERLEUKINE 6 DANS LE CARCINOME HEPATOCELLULAIRE

Bulletin du Cancer

Volumn 83, Issue 5, 1996, Pages 379-384

  Malaguarnera, M ^a   Di Fazio, I ^a   Laurino, A ^a   Romeo, M A ^a   Giugno, I ^a   Trovato, B A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

hepatitis C virus; hepatocellular carcinoma; interleukin 6

Indexed keywords

INTERLEUKIN 6; ALANINE AMINOTRANSFERASE; CHOLINESTERASE; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; PROGNOSIS; TUMOR GROWTH; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; INFLAMMATION; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GAMMA-GLOBULINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSEUDOCHOLINESTERASE;

EID: 0030140998     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Akira S, Kishimoto T. The evidence for interleukin-6 as an autocrine growth factor in malignancy. Cancer biol 1992; 3:17-26
2. Colombo M, Piva A. Virus dell'epatite C e carcinoma epatico in Occidente. Argomenti Gastroenterol Clinica 1993; 6:82-7
3. Darnis F. Problèmes étiologiques actuels posés en France par le cancer primitif du foie développé sur cirrhose. À propos de 130 observations personnelles. Ann Gastroentérol Hépatol 1991;27:322-5
4. Geisterfer M, Richards C, Baumann M, Fey G, Gywnne D, Gauldie J. Regulation of the IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. Citokine 1993;5:1-7
5. Hirano T, Kishimoto T. Interleukin-6: possible implications in human diseases. Res Clin Lab 1989;19:1-10
6. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunology Today 1990; 11:443-9
7. Kakumu S, Fukatsu A, Shinagawa T, Kurokawa S, Kusakabe A. Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease. J. Clin Pathol 1992; 45:408-11
8. Kawano M, Hirano T, Matsuda T et al. Autocrine generation and essential requirement of BSF-2/IL6 for human multiple myelomas. Nature 1988;322:83
9. Kishimoto T. The biology of interleukin 6. Blood 1989; 74:1-10
10. Michiel DF, Oppenheim JJ. Cytokines as positive and negative regulators of tumor promotion and progression. Cancer Biology 1992;3:3-15
11. Nakazaki H. Preoperative and postoperative cytokines in Patients with Cancer. Cancer 1992;70:709-13
12. Okuda K. Epidemiology of primary liver cancer. In: Primary liver cancer in Japan. Berlin: Springer-Verlag, 1992:3-15
13. Romagnani S. Le nuove interleukine. Ann Ital Med Int 1988;3:79-86
14. Sonne O, Davidsen O, Møller BK, Munk Petersen C. Cellular targets and receptors for interleukin 6. I. In vivo and in vitro uptake of interleukin 6 in liver and hepatocytes. Eur J Clin Invest 1990;20:366-70
15. Späth-Schwalbe E, Born J, Schrezenmeier H et al. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J Clin Endocrinol Metab 1994;79:1212-4
16. Trautwein C, Böker K, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms. Gut 1994;35:1163-6
17. Zohlnhofer D, Graeve L, Rose John S, Schooltink H, Dittrich E, Heinrich PC. The hepatic interleukin 6 receptor. Down regulation of the interleukin 6 binding subunit (Gp 80) by its ligand. FEBS-Lett 1992;306:219-22